Envista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
- Revenue
- +3.22%
- EPS
- +1,855.6%
- Free cash flow
- −6.48%
- Total debt
- −1.13%
Quarter to September 2026, against a year earlier
Follow NVST
Alert me
Envista Holdings Corporation (NVST) P/B ratio
As of 5 November 2026, Envista Holdings Corporation (NVST) trades at a P/B ratio of 1.3×. Over the past ten years it has ranged from 0.5× (March 2020) to 2.0× (March 2022); the current reading is higher than 56% of that period. That is below the Medical Instruments & Supplies industry median of 2.3× and below the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.2× | 3.75% |
| FY2024 | 1.1× | 17.44% |
| FY2023 | 1.0× | (26.71%) |
| FY2022 | 1.3× | (26.54%) |
| FY2021 | 1.8× | 23.73% |
| FY2020 | 1.4× | 26.96% |
| FY2019 | 1.1× | 53.84% |
| FY2018 | 0.7× | 0.00% |
| FY2017 | 0.7× | 0.00% |
| FY2016 | 0.7× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 1.2× | (11.89%) |
| Jun 2026 | 1.4× | 2.70% |
| Mar 2026 | 1.4× | 15.00% |
| Dec 2025 | 1.2× | 7.17% |
| 28 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| NVST Envista Holdings Corporation | 1.3× |
| MMED MiniMed Group, Inc. compare | 1.4× |
| ICUI ICU Medical, Inc. compare | 1.9× |
| STVN Stevanato Group S.p.A. compare | 2.0× |
| TFX Teleflex Incorporated compare | 2.3× |
| MMSI Merit Medical Systems, Inc. compare | 3.1× |
| ATRC AtriCure, Inc. compare | 5.6× |
| WRBY Warby Parker Inc. compare | 8.1× |
| PLSE Pulse Biosciences, Inc compare | 20.8× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on NVST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement